These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 26231476)

  • 1. The CHADS2 Components Are Associated with Stroke-Related In-hospital Mortality in Patients with Atrial Fibrillation.
    Yaghi S; Sherzai A; Pilot M; Sherzai D; Elkind MS
    J Stroke Cerebrovasc Dis; 2015 Oct; 24(10):2404-7. PubMed ID: 26231476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation.
    Tanaka K; Yamada T; Torii T; Furuta K; Matsumoto S; Yoshimura T; Takase K; Wakata Y; Nakashima N; Kira J; Murai H
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of antithrombotic drug use and clinical outcomes according to CHADS2 scores in patients with an initial cardioembolic stroke who had nonvalvular atrial fibrillation.
    Deguchi I; Ogawa H; Ohe Y; Nemoto M; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):846-50. PubMed ID: 22819543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation.
    Li S; Zhao X; Wang C; Liu L; Liu G; Wang Y; Wang C; Jing J; Wang YJ
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e419-25. PubMed ID: 23721617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison between CHADS2 score and CHA2DS2-VASc score on assessing the risk of ischemic stroke in patients with nonvalvular atrial fibrillation].
    Xiang W; Wang Y; Liu F; Liu M; Feng X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 May; 42(5):389-91. PubMed ID: 25042916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey.
    Marcucci M; Lip GY; Nieuwlaat R; Pisters R; Crijns HJ; Iorio A
    Am J Med; 2014 Oct; 127(10):979-986.e2. PubMed ID: 24838192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the CHA2DS2VASc score to predict postoperative stroke in patients having cardiac surgery independent of atrial fibrillation.
    Peguero JG; Issa O; Podesta C; Elmahdy HM; Santana O; Lamas GA
    Am J Cardiol; 2015 Mar; 115(6):758-62. PubMed ID: 25616533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHADS2 score predicts functional outcome of stroke in patients with a history of coronary artery disease.
    Hoshino T; Ishizuka K; Shimizu S; Uchiyama S
    J Neurol Sci; 2013 Aug; 331(1-2):57-60. PubMed ID: 23714421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CHADS
    Kondo T; Yamada T; Morita T; Furukawa Y; Tamaki S; Iwasaki Y; Kawasaki M; Kikuchi A; Kawai T; Takahashi S; Ishimi M; Hakui H; Ozaki T; Sato Y; Seo M; Sakata Y; Fukunami M
    Heart Vessels; 2017 Feb; 32(2):193-200. PubMed ID: 27325225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
    Saliba W; Rennert G
    Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predicting embolic events in patients with nonvalvular atrial fibrillation: evaluation of the CHADS2 score in a Mediterranean population].
    Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Anguita M; López Granados A; Castillo JC; Arizón JM; Suárez de Lezo J
    Rev Esp Cardiol; 2008 Jan; 61(1):29-35. PubMed ID: 18221688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is atrial fibrillation always a culprit of stroke in patients with atrial fibrillation plus stroke?
    Kim SJ; Ryoo S; Kwon S; Park YK; Kim JP; Lee GY; Bang OY
    Cerebrovasc Dis; 2013; 36(5-6):373-82. PubMed ID: 24217395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHADS₂, CHA₂S₂DS₂-VASc, and long-term stroke outcome in patients without atrial fibrillation.
    Ntaios G; Lip GY; Makaritsis K; Papavasileiou V; Vemmou A; Koroboki E; Savvari P; Manios E; Milionis H; Vemmos K
    Neurology; 2013 Mar; 80(11):1009-17. PubMed ID: 23408865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of prestroke oral anticoagulation on severity and outcome of ischemic and hemorrhagic stroke in patients with atrial fibrillation.
    Audebert HJ; Schenk B; Schenkel J; Heuschmann PU
    Cerebrovasc Dis; 2010; 29(5):476-83. PubMed ID: 20299787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-onset atrial fibrillation in severe sepsis and risk of stroke and death: a critically appraised topic.
    Lee-Iannotti JK; Capampangan DJ; Hoffman-Snyder C; Wellik KE; Patel B; Tondato F; Wingerchuk DM; Demaerschalk BM
    Neurologist; 2012 Jul; 18(4):239-43. PubMed ID: 22735257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with atrial fibrillation and an alternative primary diagnosis in the emergency department: a description of their characteristics and outcomes.
    Atzema CL; Lam K; Young C; Kester-Greene N
    Acad Emerg Med; 2013 Feb; 20(2):193-9. PubMed ID: 23406079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme.
    Rietbrock S; Heeley E; Plumb J; van Staa T
    Am Heart J; 2008 Jul; 156(1):57-64. PubMed ID: 18585497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of CHADS
    Zhou X; Cao K; Kou S; Qu S; Li H; Yu Y; Wang C; Liu Y; Li P; Li D
    Int J Cardiol; 2017 Feb; 228():906-911. PubMed ID: 27912198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.